Feinsod Matthew 4
4 · APPLIED GENETIC TECHNOLOGIES CORP · Filed Jan 15, 2019
Insider Transaction Report
Form 4
Feinsod Matthew
Interim Chief Medical Officer
Transactions
- Award
Common Stock
2019-01-11+2,000→ 48,791 total - Tax Payment
Common Stock
2019-01-11$3.20/sh−713$2,282→ 48,078 total
Footnotes (1)
- [F1]The common stock vested immediately upon grant.